Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Suspends Part B CAP As Vendors Avoid Program; Overhaul May Follow

Executive Summary

The competitive acquisition program for Medicare Part B drugs and biologics will be put on hold in 2009 because of a lack of interest among specialty drug distributors in becoming approved vendors

You may also be interested in...



Part B Drug Competitive Bidding Program Revival: Vendor Request Coming Soon

Distributors, specialty pharmacies and PBMs are in a better position now to act as vendors then they were a decade ago, when Medicare unsuccessfully tried to implement a Medicare Part B prescription drug competitive acquisition program, HHS Secretary Azar points out.

Part B Reference Pricing Faces 'Clinical' As Well As 'Political' Obstacles

Medicare pilot program on value-based purchasing could be challenged by a lack of therapeutic consensus as much as by opposition towards reduced reimbursement.

Part B CAP Fix Could Take Creative Thinking, But Law Limits Flexibility

Figuring out how the Medicare Part B competitive acquisition program can be made more attractive for specialty drug distributors within the confines of the statute could be a tall order for CMS

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS050088

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel